A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors

✍ Scribed by Matthew G. Fury; David B. Solit; Yungpo Bernard Su; Neal Rosen; F. M. Sirotnak; Robert P. Smith; Christopher G. Azzoli; Jorge E. Gomez; Vincent A. Miller; Mark G. Kris; Barbara A. Pizzo; Roxanne Henry; David G. Pfister; Naiyer A. Rizvi

• Publisher: Springer
• Year: 2006
• Tongue: English
• Weight: 387 KB
• Volume: 59
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-006-0286-6